![Nishant Saxena](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 531 278 $ al 30/09/2026
Nishant Saxena is currently Chief Business Officer at Corbus Pharmaceuticals Holdings, Inc. since 2026.
Formerly, Mr. Saxena was Chief Financial Officer at Jeune Aesthetics, Inc. Education includes undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/08/2026 | 77.900 ( 0,4 % ) | 531 278 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Corporate Officer/Principal | 21/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Jeune Aesthetics, Inc.
 Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
